Penumbra (NYSE: PEN)
Penumbra Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Penumbra Company Info
Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device (POD) system. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004, and is headquartered in Alameda, CA.
News & Analysis
This Medical Device Company Just Got a Big Boost
If you like good news and support from experts, this one's for you.
Why Penumbra Stock Sank Today
The company announced a product recall, prompting several analysts' downgrades.
Why Penumbra Stock Is Plunging Today
Investors are rattled by a short-seller's report.
Why Penumbra Stock Is Popping Today
The healthcare company posted better-than-expected Q3 results.
3 Highest Growth Stocks in the Market Today
Profit growth doesn't get any faster than this.
Why Penumbra Inc Is Skyrocketing Today
A good looking earnings report sends shares of the newly public medical device maker soaring higher.
Valuation
Earnings Transcripts
Penumbra, Inc (PEN) Q3 2021 Earnings Call Transcript
PEN earnings call for the period ending September 30, 2021.
Penumbra, inc (PEN) Q2 2021 Earnings Call Transcript
PEN earnings call for the period ending June 30, 2021.
Penumbra Inc (PEN) Q1 2021 Earnings Call Transcript
PEN earnings call for the period ending March 31, 2021.
Penumbra Inc (PEN) Q4 2020 Earnings Call Transcript
PEN earnings call for the period ending December 31, 2020.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.